Proficio Capital Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,955
Closed -$870K 427
2025
Q2
$870K Sell
1,955
-124
-6% -$57.1K 0.05% 171
2025
Q1
$1.01M Buy
2,079
+1,101
+113% +$513K 0.08% 129
2024
Q4
$394K Buy
978
+311
+47% +$144K 0.03% 226
2024
Q3
$310K Sell
667
-179
-21% -$86K 0.03% 213
2024
Q2
$397K Buy
846
+23
+3% +$9.98K 0.04% 198
2024
Q1
$344K Buy
823
+34
+4% +$14.4K 0.04% 222
2023
Q4
$321K Sell
789
-4
-0.5% -$1.48K 0.04% 213
2023
Q3
$276K Buy
793
+73
+10% +$25.5K 0.04% 231
2023
Q2
$253K Buy
720
+32
+5% +$10.8K 0.03% 243
2023
Q1
$217K Buy
+688
New +$206K 0.03% 265
2020
Q4
Sell
-757
Closed -$206K 197
2020
Q3
$206K Buy
757
+22
+3% +$6.07K 0.04% 163
2020
Q2
$213K Buy
+735
New +$199K 0.04% 157
2019
Q3
Sell
-333
Closed -$61K 1507
2019
Q2
$61K Buy
333
+14
+4% +$2.45K 0.02% 317
2019
Q1
$59K Buy
319
+66
+26% +$12.2K 0.02% 298
2018
Q4
$42K Sell
253
-5
-2% -$866 0.02% 342
2018
Q3
$50K Buy
258
+8
+3% +$1.43K 0.02% 356
2018
Q2
$42K Buy
250
+10
+4% +$1.55K 0.02% 403
2018
Q1
$39K Sell
240
-8
-3% -$1.31K 0.02% 418
2017
Q4
$37K Sell
248
-52
-17% -$7.7K 0.01% 423
2017
Q3
$46K Buy
300
+19
+7% +$2.86K 0.02% 399
2017
Q2
$44K Buy
281
+31
+12% +$3.73K 0.02% 411
2017
Q1
$29K Buy
250
+172
+221% +$15.1K 0.01% 520
2016
Q4
$6K Buy
78
+7
+10% +$570 ﹤0.01% 727
2016
Q3
$6K Buy
71
+13
+22% +$1.23K ﹤0.01% 691
2016
Q2
$6K Buy
58
+54
+1,350% +$4.67K ﹤0.01% 671
2016
Q1
$0 Sell
4
-41
-91% -$3.71K ﹤0.01% 1180
2015
Q4
$6K Buy
+45
New +$5.43K 0.01% 397

Other funds holding VRTX